ID   VGF_RAT                 Reviewed;         617 AA.
AC   P20156;
DT   01-FEB-1991, integrated into UniProtKB/Swiss-Prot.
DT   26-MAY-2009, sequence version 3.
DT   02-OCT-2024, entry version 132.
DE   RecName: Full=Neurosecretory protein VGF;
DE   AltName: Full=VGF8a protein;
DE   Contains:
DE     RecName: Full=VGF(24-63);
DE   Contains:
DE     RecName: Full=VGF(180-194);
DE   Contains:
DE     RecName: Full=VGF(375-407);
DE   Contains:
DE     RecName: Full=Neuroendocrine regulatory peptide-1;
DE              Short=NERP-1;
DE   Contains:
DE     RecName: Full=Neuroendocrine regulatory peptide-2;
DE              Short=NERP-2;
DE   Contains:
DE     RecName: Full=VGF-derived peptide TLQP-11;
DE   Contains:
DE     RecName: Full=VGF-derived peptide TLQP-21;
DE   Contains:
DE     RecName: Full=VGF-derived peptide TLQP-30;
DE   Contains:
DE     RecName: Full=VGF-derived peptide TLQP-62;
DE   Contains:
DE     RecName: Full=VGF-derived peptide HFHH-10;
DE   Contains:
DE     RecName: Full=VGF-derived peptide AQEE-30;
DE   Contains:
DE     RecName: Full=VGF-derived peptide LQEQ-19;
DE   Flags: Precursor;
GN   Name=Vgf;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2676516; DOI=10.1002/j.1460-2075.1989.tb08345.x;
RA   Possenti R., Eldridge J.D., Paterson B.M., Grasso A., Levi A.;
RT   "A protein induced by NGF in PC12 cells is stored in secretory vesicles and
RT   released through the regulated pathway.";
RL   EMBO J. 8:2217-2223(1989).
RN   [2]
RP   SEQUENCE REVISION.
RA   Possenti R.;
RL   Submitted (OCT-1995) to UniProtKB.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RX   PubMed=2017159; DOI=10.1128/mcb.11.5.2335-2349.1991;
RA   Salton S.R.J., Fischberg D.J., Dong K.-W.;
RT   "Structure of the gene encoding VGF, a nervous system-specific mRNA that is
RT   rapidly and selectively induced by nerve growth factor in PC12 cells.";
RL   Mol. Cell. Biol. 11:2335-2349(1991).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=1377233; DOI=10.1523/jneurosci.12-07-02573.1992;
RA   Hawley R.J., Scheibe R.J., Wagner J.A.;
RT   "NGF induces the expression of the VGF gene through a cAMP response
RT   element.";
RL   J. Neurosci. 12:2573-2581(1992).
RN   [5]
RP   FUNCTION (NEUROSECRETORY PROTEIN VGF).
RX   PubMed=7595538; DOI=10.1046/j.1471-4159.1995.65062441.x;
RA   Trani E., Ciotti T., Rinaldi A.M., Canu N., Ferri G.L., Levi A.,
RA   Possenti R.;
RT   "Tissue-specific processing of the neuroendocrine protein VGF.";
RL   J. Neurochem. 65:2441-2449(1995).
RN   [6]
RP   FUNCTION (NEUROSECRETORY PROTEIN VGF), AND TISSUE SPECIFICITY.
RX   PubMed=12065665; DOI=10.1046/j.1471-4159.2002.00842.x;
RA   Trani E., Giorgi A., Canu N., Amadoro G., Rinaldi A.M., Halban P.A.,
RA   Ferri G.L., Possenti R., Schinina M.E., Levi A.;
RT   "Isolation and characterization of VGF peptides in rat brain. Role of PC1/3
RT   and PC2 in the maturation of VGF precursor.";
RL   J. Neurochem. 81:565-574(2002).
RN   [7]
RP   FUNCTION (VGF-DERIVED PEPTIDE TLQP-21).
RX   PubMed=16983076; DOI=10.1073/pnas.0606102103;
RA   Bartolomucci A., La Corte G., Possenti R., Locatelli V., Rigamonti A.E.,
RA   Torsello A., Bresciani E., Bulgarelli I., Rizzi R., Pavone F.,
RA   D'Amato F.R., Severini C., Mignogna G., Giorgi A., Schinina M.E., Elia G.,
RA   Brancia C., Ferri G.L., Conti R., Ciani B., Pascucci T., Dell'Omo G.,
RA   Muller E.E., Levi A., Moles A.;
RT   "TLQP-21, a VGF-derived peptide, increases energy expenditure and prevents
RT   the early phase of diet-induced obesity.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:14584-14589(2006).
RN   [8]
RP   PROTEIN SEQUENCE OF 24-63; 180-194 AND 375-407, MASS SPECTROMETRY, AND
RP   PYROGLUTAMATE FORMATION AT GLN-180.
RC   STRAIN=Wistar; TISSUE=Corpus striatum;
RX   PubMed=19164277; DOI=10.1074/mcp.m800501-mcp200;
RA   Bernay B., Gaillard M.-C., Guryca V., Emadali A., Kuhn L., Bertrand A.,
RA   Detraz I., Carcenac C., Savasta M., Brouillet E., Garin J., Elalouf J.-M.;
RT   "Discovering new bioactive neuropeptides in the striatum secretome using in
RT   vivo microdialysis and versatile proteomics.";
RL   Mol. Cell. Proteomics 8:946-958(2009).
RN   [9]
RP   FUNCTION (VGF-DERIVED PEPTIDE TLQP-21).
RX   PubMed=19466987; DOI=10.1111/j.1476-5381.2009.00192.x;
RA   Severini C., La Corte G., Improta G., Broccardo M., Agostini S.,
RA   Petrella C., Sibilia V., Pagani F., Guidobono F., Bulgarelli I.,
RA   Ferri G.L., Brancia C., Rinaldi A.M., Levi A., Possenti R.;
RT   "In vitro and in vivo pharmacological role of TLQP-21, a VGF-derived
RT   peptide, in the regulation of rat gastric motor functions.";
RL   Br. J. Pharmacol. 157:984-993(2009).
RN   [10]
RP   FUNCTION (NEUROENDOCRINE REGULATORY PEPTIDE-1), FUNCTION (NEUROENDOCRINE
RP   REGULATORY PEPTIDE-2), PYROGLUTAMATE FORMATION AT GLN-313, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=19194657; DOI=10.1007/s00018-009-8796-0;
RA   Toshinai K., Nakazato M.;
RT   "Neuroendocrine regulatory peptide-1 and -2: novel bioactive peptides
RT   processed from VGF.";
RL   Cell. Mol. Life Sci. 66:1939-1945(2009).
RN   [11]
RP   FUNCTION (NEUROENDOCRINE REGULATORY PEPTIDE-2).
RX   PubMed=20551287; DOI=10.1152/ajpendo.00768.2009;
RA   Toshinai K., Yamaguchi H., Kageyama H., Matsuo T., Koshinaka K., Sasaki K.,
RA   Shioda S., Minamino N., Nakazato M.;
RT   "Neuroendocrine regulatory peptide-2 regulates feeding behavior via the
RT   orexin system in the hypothalamus.";
RL   Am. J. Physiol. 299:E394-E401(2010).
RN   [12]
RP   FUNCTION (VGF-DERIVED PEPTIDE TLQP-21), AND INTERACTION WITH C3AR1
RP   (VGF-DERIVED PEPTIDE TLQP-21).
RX   PubMed=23940034; DOI=10.1074/jbc.m113.497214;
RA   Hannedouche S., Beck V., Leighton-Davies J., Beibel M., Roma G.,
RA   Oakeley E.J., Lannoy V., Bernard J., Hamon J., Barbieri S., Preuss I.,
RA   Lasbennes M.C., Sailer A.W., Suply T., Seuwen K., Parker C.N.,
RA   Bassilana F.;
RT   "Identification of the C3a receptor (C3AR1) as the target of the VGF-
RT   derived peptide TLQP-21 in rodent cells.";
RL   J. Biol. Chem. 288:27434-27443(2013).
RN   [13]
RP   FUNCTION (VGF-DERIVED PEPTIDE TLQP-21), AND INTERACTION WITH C1QBP
RP   (VGF-DERIVED PEPTIDE TLQP-21).
RX   PubMed=24106277; DOI=10.1074/jbc.m113.510917;
RA   Chen Y.C., Pristera A., Ayub M., Swanwick R.S., Karu K., Hamada Y.,
RA   Rice A.S., Okuse K.;
RT   "Identification of a receptor for neuropeptide VGF and its role in
RT   neuropathic pain.";
RL   J. Biol. Chem. 288:34638-34646(2013).
RN   [14]
RP   FUNCTION (NEUROENDOCRINE REGULATORY PEPTIDE-1), AND FUNCTION
RP   (NEUROENDOCRINE REGULATORY PEPTIDE-2).
RX   PubMed=24704271; DOI=10.1016/j.brainres.2014.03.038;
RA   Toshinai K., Saito T., Yamaguchi H., Sasaki K., Tsuchimochi W.,
RA   Minamino N., Ueta Y., Nakazato M.;
RT   "Neuroendocrine regulatory peptide-1 and -2 (NERPs) inhibit the
RT   excitability of magnocellular neurosecretory cells in the hypothalamus.";
RL   Brain Res. 1563:52-60(2014).
RN   [15]
RP   FUNCTION (VGF-DERIVED PEPTIDE TLQP-62).
RX   PubMed=25917832; DOI=10.1530/jme-14-0313;
RA   Petrocchi-Passeri P., Cero C., Cutarelli A., Frank C., Severini C.,
RA   Bartolomucci A., Possenti R.;
RT   "The VGF-derived peptide TLQP-62 modulates insulin secretion and glucose
RT   homeostasis.";
RL   J. Mol. Endocrinol. 54:227-239(2015).
RN   [16]
RP   FUNCTION (NEUROENDOCRINE REGULATORY PEPTIDE-2).
RX   PubMed=28213131; DOI=10.1016/j.bbrc.2017.02.064;
RA   Namkoong C., Toshinai K., Waise T.M.Z., Sakoda H., Sasaki K., Ueta Y.,
RA   Kim M.S., Minamino N., Nakazato M.;
RT   "NERP-2 regulates gastric acid secretion and gastric emptying via the
RT   orexin pathway.";
RL   Biochem. Biophys. Res. Commun. 485:409-413(2017).
RN   [17]
RP   FUNCTION (VGF-DERIVED PEPTIDE TLQP-21).
RX   PubMed=28123945; DOI=10.1016/j.molmet.2016.10.005;
RA   Cero C., Razzoli M., Han R., Sahu B.S., Patricelli J., Guo Z.,
RA   Zaidman N.A., Miles J.M., O'Grady S.M., Bartolomucci A.;
RT   "The neuropeptide TLQP-21 opposes obesity via C3aR1-mediated enhancement of
RT   adrenergic-induced lipolysis.";
RL   Mol. Metab. 6:148-158(2017).
CC   -!- FUNCTION: [Neurosecretory protein VGF]: Secreted polyprotein that is
CC       packaged and proteolytically processed by prohormone convertases PCSK1
CC       and PCSK2 in a cell-type-specific manner (PubMed:12065665,
CC       PubMed:7595538). VGF and peptides derived from its processing play many
CC       roles in neurogenesis and neuroplasticity associated with learning,
CC       memory, depression and chronic pain (By similarity).
CC       {ECO:0000250|UniProtKB:Q0VGU4, ECO:0000269|PubMed:12065665,
CC       ECO:0000269|PubMed:7595538}.
CC   -!- FUNCTION: [Neuroendocrine regulatory peptide-1]: Plays a role in the
CC       control of body fluid homeostasis by regulating vasopressin release.
CC       Suppresses presynaptic glutamatergic neurons connected to vasopressin
CC       neurons. {ECO:0000269|PubMed:24704271}.
CC   -!- FUNCTION: [Neuroendocrine regulatory peptide-2]: Plays a role in the
CC       control of body fluid homeostasis by regulating vasopressin release.
CC       Activates GABAergic interneurons which are inhibitory neurons of the
CC       nervous system and thereby suppresses presynaptic glutamatergic neurons
CC       (PubMed:24704271). Stimulates also feeding behavior in an orexin-
CC       dependent manner in the hypothalamus (PubMed:20551287). Functions as a
CC       positive regulator for the activation of orexin neurons resulting in
CC       elevated gastric acid secretion and gastric emptying (PubMed:28213131).
CC       {ECO:0000269|PubMed:20551287, ECO:0000269|PubMed:24704271,
CC       ECO:0000269|PubMed:28213131}.
CC   -!- FUNCTION: [VGF-derived peptide TLQP-21]: Secreted multifunctional
CC       neuropeptide that binds to different cell receptors and thereby plays
CC       multiple physiological roles including modulation of energy
CC       expenditure, pain, response to stress, gastric regulation, glucose
CC       homeostasis as well as lipolysis (PubMed:16983076, PubMed:28123945).
CC       Activates the G-protein-coupled receptor C3AR1 via a folding-upon-
CC       binding mechanism leading to enhanced lipolysis in adipocytes
CC       (PubMed:23940034, PubMed:28123945). Interacts with C1QBP receptor in
CC       macrophages and microglia causing increased levels of intracellular
CC       calcium and hypersensitivity (PubMed:19466987, PubMed:24106277).
CC       {ECO:0000269|PubMed:16983076, ECO:0000269|PubMed:19466987,
CC       ECO:0000269|PubMed:23940034, ECO:0000269|PubMed:24106277,
CC       ECO:0000269|PubMed:28123945}.
CC   -!- FUNCTION: [VGF-derived peptide TLQP-62]: Plays a role in the regulation
CC       of memory formation and depression-related behaviors potentially by
CC       influencing synaptic plasticity and neurogenesis. Induces acute and
CC       transient activation of the NTRK2/TRKB receptor and subsequent CREB
CC       phosphorylation (By similarity). Induces also insulin secretion in
CC       insulinoma cells by increasing intracellular calcium mobilization
CC       (PubMed:25917832). {ECO:0000250|UniProtKB:Q0VGU4,
CC       ECO:0000269|PubMed:25917832}.
CC   -!- SUBUNIT: [VGF-derived peptide TLQP-21]: Interacts with HSPA8 on cell
CC       membrane (By similarity). Interacts with C3AR1 (By similarity).
CC       Interacts with C1QBP (PubMed:24106277). {ECO:0000250|UniProtKB:O15240,
CC       ECO:0000250|UniProtKB:Q0VGU4, ECO:0000269|PubMed:24106277}.
CC   -!- SUBCELLULAR LOCATION: [Neurosecretory protein VGF]: Secreted
CC       {ECO:0000250|UniProtKB:O15240}. Cytoplasmic vesicle, secretory vesicle
CC       {ECO:0000250|UniProtKB:O15240}. Note=Stored in secretory vesicles and
CC       then secreted, NERP peptides colocalize with vasopressin in the storage
CC       granules of hypothalamus. {ECO:0000250|UniProtKB:O15240}.
CC   -!- TISSUE SPECIFICITY: Central and peripheral nervous systems, synthesized
CC       exclusively in neuronal and neuroendocrine cells. VGF and several of
CC       the derived peptides are present in the brain.
CC       {ECO:0000269|PubMed:12065665, ECO:0000269|PubMed:19194657}.
CC   -!- INDUCTION: By nerve growth factor.
CC   -!- PTM: Multiple peptides are derived from VGF, with activities in
CC       synaptic plasticity, antidepression, penile erection, autonomic
CC       activation, and increases in energy expenditure.
CC   -!- MASS SPECTROMETRY: [VGF(24-63)]: Mass=4164.694; Method=Electrospray;
CC       Evidence={ECO:0000269|PubMed:19164277};
CC   -!- MASS SPECTROMETRY: [VGF(180-194)]: Mass=1655.730; Method=Electrospray;
CC       Evidence={ECO:0000269|PubMed:19164277};
CC   -!- MASS SPECTROMETRY: [VGF(375-407)]: Mass=3470.868; Method=Electrospray;
CC       Evidence={ECO:0000269|PubMed:19164277};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M60522; AAA41700.1; -; Genomic_DNA.
DR   EMBL; M60525; AAA86428.1; -; mRNA.
DR   EMBL; M74223; AAA42336.1; -; mRNA.
DR   PIR; I56530; I56530.
DR   PIR; S05381; S05381.
DR   RefSeq; NP_112259.1; NM_030997.1.
DR   AlphaFoldDB; P20156; -.
DR   SMR; P20156; -.
DR   BioGRID; 248104; 1.
DR   IntAct; P20156; 1.
DR   MINT; P20156; -.
DR   STRING; 10116.ENSRNOP00000050024; -.
DR   CarbonylDB; P20156; -.
DR   iPTMnet; P20156; -.
DR   PhosphoSitePlus; P20156; -.
DR   jPOST; P20156; -.
DR   PaxDb; 10116-ENSRNOP00000050024; -.
DR   Ensembl; ENSRNOT00000041808.3; ENSRNOP00000050024.3; ENSRNOG00000001416.6.
DR   Ensembl; ENSRNOT00055000270; ENSRNOP00055000165; ENSRNOG00055000169.
DR   Ensembl; ENSRNOT00055000271; ENSRNOP00055000166; ENSRNOG00055000169.
DR   Ensembl; ENSRNOT00060019478; ENSRNOP00060015294; ENSRNOG00060011506.
DR   Ensembl; ENSRNOT00060019486; ENSRNOP00060015302; ENSRNOG00060011506.
DR   Ensembl; ENSRNOT00065002173; ENSRNOP00065001521; ENSRNOG00065001616.
DR   Ensembl; ENSRNOT00065002174; ENSRNOP00065001522; ENSRNOG00065001616.
DR   GeneID; 29461; -.
DR   KEGG; rno:29461; -.
DR   UCSC; RGD:69399; rat.
DR   AGR; RGD:69399; -.
DR   CTD; 7425; -.
DR   RGD; 69399; Vgf.
DR   eggNOG; ENOG502S5N4; Eukaryota.
DR   GeneTree; ENSGT00390000017745; -.
DR   InParanoid; P20156; -.
DR   OMA; EMPGHRR; -.
DR   OrthoDB; 5359558at2759; -.
DR   PhylomeDB; P20156; -.
DR   Reactome; R-RNO-381426; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs).
DR   Reactome; R-RNO-8957275; Post-translational protein phosphorylation.
DR   PRO; PR:P20156; -.
DR   Proteomes; UP000002494; Chromosome 12.
DR   GO; GO:0031410; C:cytoplasmic vesicle; ISO:RGD.
DR   GO; GO:0005615; C:extracellular space; ISO:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:Ensembl.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0045202; C:synapse; IDA:SynGO.
DR   GO; GO:0030133; C:transport vesicle; IEA:UniProtKB-SubCell.
DR   GO; GO:0008083; F:growth factor activity; IEA:UniProtKB-KW.
DR   GO; GO:0005179; F:hormone activity; IBA:GO_Central.
DR   GO; GO:0005184; F:neuropeptide hormone activity; ISO:RGD.
DR   GO; GO:0033500; P:carbohydrate homeostasis; IBA:GO_Central.
DR   GO; GO:0006091; P:generation of precursor metabolites and energy; ISO:RGD.
DR   GO; GO:0042593; P:glucose homeostasis; ISO:RGD.
DR   GO; GO:0030073; P:insulin secretion; ISO:RGD.
DR   GO; GO:0050804; P:modulation of chemical synaptic transmission; IDA:SynGO.
DR   GO; GO:0030182; P:neuron differentiation; TAS:RGD.
DR   GO; GO:0001541; P:ovarian follicle development; ISO:RGD.
DR   GO; GO:0048168; P:regulation of neuronal synaptic plasticity; IDA:RGD.
DR   GO; GO:0048167; P:regulation of synaptic plasticity; IBA:GO_Central.
DR   GO; GO:0051591; P:response to cAMP; ISO:RGD.
DR   GO; GO:0009409; P:response to cold; ISO:RGD.
DR   GO; GO:0002021; P:response to dietary excess; ISO:RGD.
DR   GO; GO:0032868; P:response to insulin; ISO:RGD.
DR   GO; GO:0019953; P:sexual reproduction; ISO:RGD.
DR   GO; GO:0007165; P:signal transduction; ISO:RGD.
DR   GO; GO:0099538; P:synaptic signaling via neuropeptide; IDA:SynGO.
DR   InterPro; IPR026128; VGF.
DR   PANTHER; PTHR15159; NEUROSECRETORY PROTEIN VGF; 1.
DR   PANTHER; PTHR15159:SF2; NEUROSECRETORY PROTEIN VGF; 1.
PE   1: Evidence at protein level;
KW   Amidation; Cleavage on pair of basic residues; Cytoplasmic vesicle;
KW   Direct protein sequencing; Growth factor; Phosphoprotein;
KW   Pyrrolidone carboxylic acid; Reference proteome; Secreted; Signal.
FT   SIGNAL          1..23
FT                   /evidence="ECO:0000255"
FT   CHAIN           24..617
FT                   /note="Neurosecretory protein VGF"
FT                   /id="PRO_0000022656"
FT   PEPTIDE         24..63
FT                   /note="VGF(24-63)"
FT                   /id="PRO_0000375995"
FT   PEPTIDE         180..194
FT                   /note="VGF(180-194)"
FT                   /id="PRO_0000375996"
FT   PEPTIDE         285..309
FT                   /note="Neuroendocrine regulatory peptide-1"
FT                   /id="PRO_0000403366"
FT   PEPTIDE         313..350
FT                   /note="Neuroendocrine regulatory peptide-2"
FT                   /id="PRO_0000403367"
FT   PEPTIDE         375..407
FT                   /note="VGF(375-407)"
FT                   /id="PRO_0000375997"
FT   PEPTIDE         556..617
FT                   /note="VGF-derived peptide TLQP-62"
FT                   /id="PRO_0000403368"
FT   PEPTIDE         556..587
FT                   /note="VGF-derived peptide TLQP-30"
FT                   /id="PRO_0000403369"
FT   PEPTIDE         556..576
FT                   /note="VGF-derived peptide TLQP-21"
FT                   /id="PRO_0000403370"
FT   PEPTIDE         556..566
FT                   /note="VGF-derived peptide TLQP-11"
FT                   /id="PRO_0000403371"
FT   PEPTIDE         567..576
FT                   /note="VGF-derived peptide HFHH-10"
FT                   /id="PRO_0000403372"
FT   PEPTIDE         588..617
FT                   /note="VGF-derived peptide AQEE-30"
FT                   /id="PRO_0000403373"
FT   PEPTIDE         599..617
FT                   /note="VGF-derived peptide LQEQ-19"
FT                   /id="PRO_0000403374"
FT   REGION          29..75
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          94..113
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          121..157
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          169..192
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          348..603
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        46..61
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        121..143
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        354..378
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        379..394
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        395..438
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        439..455
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        472..492
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        493..520
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        526..541
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        574..603
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         180
FT                   /note="Pyrrolidone carboxylic acid"
FT                   /evidence="ECO:0000269|PubMed:19164277"
FT   MOD_RES         313
FT                   /note="Pyrrolidone carboxylic acid"
FT                   /evidence="ECO:0000269|PubMed:19194657"
FT   MOD_RES         423
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O15240"
FT   CONFLICT        342
FT                   /note="G -> A (in Ref. 1)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   617 AA;  68179 MW;  5E23E47DF460C7B4 CRC64;
     MKTFTLPASV LFCFLLLIRG LGAAPPGRSD VYPPPLGSEH NGQVAEDAVS RPKDDSVPEV
     RAARNSEPQD QGELFQGVDP RALAAVLLQA LDRPASPPAV PAGSQQGTPE EAAEALLTES
     VRSQTHSLPA SEIQASAVAP PRPQTQDNDP EADDRSEELE ALASLLQELR DFSPSNAKRQ
     QETAAAETET RTHTLTRVNL ESPGPERVWR ASWGEFQARV PERAPLPPSV PSQFQARMSE
     NVPLPETHQF GEGVSSPKTH LGETLTPLSK AYQSLSAPFP KVRRLEGSFL GGSEAGERLL
     QQGLAQVEAG RRQAEATRQA AAQEERLADL ASDLLLQYLL QGGARQRDLG GRGLQETQQE
     RENEREEEAE QERRGGGEDE VGEEDEEAAE AEAEAEEAER ARQNALLFAE EEDGEAGAED
     KRSQEEAPGH RRKDAEGTEE GGEEDDDDEE MDPQTIDSLI ELSTKLHLPA DDVVSIIEEV
     EEKRKRKKNA PPEPVPPPRA APAPTHVRSP QPPPPAPARD ELPDWNEVLP PWDREEDEVF
     PPGPYHPFPN YIRPRTLQPP ASSRRRHFHH ALPPARHHPD LEAQARRAQE EADAEERRLQ
     EQEELENYIE HVLLHRP
//
